This program is intended for adult and pediatric endocrinology specialists (MDs, NPs, PAs), primary care/family medicine providers (MDs, NPs, PAs), scientists, researchers, and other healthcare professionals who manage adult and pediatric patients with growth hormone deficiency.
The goal of this program is to improve the knowledge and competence of learners to improve the timely diagnosis and optimize treatment for patients with growth hormone deficiency.
Apply the appropriate diagnostic tests to a patient with a high suspicion of GHD
Evaluate the efficacy and safety of long-acting growth hormone therapies in pediatric and adult patients with GHD
Develop comprehensive treatment plans for patients with GHD, including agent selection, dosing, and monitoring
Implement strategies to improve treatment adherence and transitions of care for patients with GHD
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:
Sara Divall, MD
Associate Professor, Pediatrics
Center for Clinical and Translational Research
Endocrinology Fellowship Director
Seattle Children’s Endocrinology
University of Washington Medicine
Sara DiVall, MD: has no relevant financial relationships to disclose.
Andrew Hoffman, MD
Professor of Medicine
Stanford University School of Medicine
Andrew Hoffman, MD: consultant/advisor/speaker: Ascendis, Novo Nordisk.
Laurence Katznelson, MD
Professor of Medicine (Endocrinology) and Neurosurgery
Associate Dean of Graduate Medical Education
Medical Director, Pituitary Center
Stanford Health Care, Stanford School of Medicine
Laurence Katznelson, MD: consultant/advisor/speaker: Novo Nordisk, Recordati, Pfizer, Stonebridge; researcher: Camarus, Novartis.
The planners and content peer reviewers from Clinical Care Options, LLC and Endocrine Society do not have any relevant financial relationships to disclose, except Amy Butts, PA-C as noted below:
Amy Butts, PA-C: consultant/advisor/speaker: Abbott, Bayer, Novo Nordisk, Sanofi.
The program has been made available online.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.
AMA PRA Category 1 Credit
The Endocrine Society designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.
Joint Accreditation Statement
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.5 contact hours.
Physician Associate/Physician Assistant Continuing Medical Education
Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. Approval is valid until August 03, 2024. PAs should only claim credit commensurate with the extent of their participation.